1M6MYTD1Y5YMAX
Loading quotes...
Forecast
There is no analyst data available for this company.
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 294.41k | - |
| Gross profit | 69.22k | 8.258,76% |
| Net profit | −354.87k | 68,27% |
| EBITDA | −365.38k | 67,25% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | 4.14m€ |
Number of shares | 5.52m |
52-week high/low | 7,57€ - 0,49€ |
Dividend yield | 17,06% |
Dividends TTM | 0,13€ |
Beta | -0,4 |
P/E ratio | −0,24 |
PEG ratio | 0,00 |
P/B ratio | 0,68 |
P/S ratio | 2,59 |
Company profile
| Name | Cyclacel Pharmaceuticals |
| CEO | Sing Ee Wong |
| Headquarters | Kuala Lumpur,
lf USA |
| Sector | Materials |
| Industry | Chemicals |
| Employees | 12 |
Discover assets
Shareholders of Cyclacel Pharmaceuticals also invest in the following assets
